5 big analyst AI moves: Apple lifted to Buy, AI chip bets reassessed
LONDON - Eden Research plc (AIM:EDEN), a company focused on sustainable biopesticide and biocontrol technology, will release its interim financial results for the six months ended June 30, 2025, on September 17, 2025, according to a press release statement issued Monday.
The company’s CEO Sean Smith and CFO Alex Abrey will deliver a live presentation about the results via Investor Meet Company on September 17 at 11:00 BST. The presentation will be open to existing and potential shareholders, who can submit questions before or during the event.
Eden Research describes itself as the only UK-listed company focused on biopesticides for sustainable agriculture. The company develops products formulated with terpene active ingredients based on natural plant defense metabolites.
The company currently has three products on the market: Mevalone, a foliar biofungicide targeting diseases affecting grapes and other high-value crops; Cedroz, a bionematicide for parasitic worms affecting fruit and vegetable crops; and Ecovelex, a seed treatment product designed to repel birds from crops.
Eden Research was admitted to trading on AIM on May 11, 2012, and received the London Stock Exchange Green Economy Mark in January 2021, which recognizes companies that derive over 50% of their annual revenue from products contributing to the green economy.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.